International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Journal of Thrombosis and Haemostasis2012Vol. 11(1), pp. 56–70
Citations Over TimeTop 1% of 2012 papers
Dominique Farge, P. Debourdeau, M. Beckers, Caroline Baglin, Rupert Bauersachs, Benjamin Brenner, Dialina Brilhante, Anna Falanga, G.T. GEROTZAFIAS, Nissim Haim, A. K. Kakkar, Alok A. Khorana, Ramón Lecumberri, Mario Mandalà, Michel Marty, Manuel Monréal, Shaker A. Mousa, Simon Noble, Ingrid Pabinger, Paolo Prandoni, Martin H. Prins, Mohamad Qari, Michael B. Streiff, K. Syrigos, Henri Bounameaux, Harry R. Büller
Related Papers
- → Retrospective Analysis of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Women With Recurrent Spontaneous Abortion(2021)15 cited
- → CV1 COST-EFFECTIVENESS OF FONDAPARINUX VS ENOXAPARIN AS PROPHYLAXIS AGAINST VENOUS THROMBOEMBOLISM FOLLOWING ORTHOPAEDIC SURGERY(2002)4 cited
- → PCV62 CLINICAL AND ECONOMIC OUTCOMES OF FONDAPARINUX VS. ENOXAPARIN IN THE PROPHYLAXIS OF VENOUS THROMBOEMBOLISM AFTER MAJOR ORTHOPAEDIC SURGERY IN SPAIN(2003)2 cited
- → PBR5 COST-EFFECTIVENESS OF EXTENDED VENOUS THROMBOEMBOLISM PROPHYLAXIS WITH FONDAPARINUX IN MAJOR ORTHOPAEDIC SURGERY IN SWITZERLAND(2004)
- Fondaparinux: new preparation. No better than LMWH in preventing pulmonary embolism.(2003)